Safety Syringe Ad Auto Disable Vaccine Syringe
Product Parameters Product nameRegular syringeSyringe with detachable needle(Standard)Syringe with fixed needle(Auto- disabled)Syringe with fixed needleNeedle26G-31G26G-31G26G-31G26G-31GVolume1ml0.05-1ml0.3ml, 0.5ml, 1ml0.3ml, 0.5ml, 1mlStructure Properties of ProductsWith self-destructive character......
Send Inquiry
Product Description
| Product name | Regular syringe | Syringe with detachable needle (Standard) | Syringe with fixed needle (Auto- disabled) | Syringe with fixed needle |
| Needle | 26G-31G | 26G-31G | 26G-31G | 26G-31G |
| Volume | 1ml | 0.05-1ml | 0.3ml, 0.5ml, 1ml | 0.3ml, 0.5ml, 1ml |
•With self-destructive characteristics, the self-
destructive performance of the syringe will begin to
take effect as the injection starts. When the fixed dose
of vaccine is finished, the syringe will be completely
self-locked , effectively preventing the reuse of the
syringe and improving the safety of medical injection.
•The integrated design of the needle holder and barrel
injection molding which ensures the low residue of
the liquid and ensures the accuracy of the injection of
the liquid.
•Firm adhesion of the ink of scale , friction
resistance ,not easy to fall off.
•Good usability design: The barrel is transparent and
can clearly observe the liquid and bubbles; the
mandrel press is provided with anti-skid structure,
which is easy to be hold.
•The plunger has obvious concave steps with equal
visible distance in the same plane, which can be used
to set up the self-destructive area to ensure the self-
destructive effect is high and reliable.
Increase of 2-19% additional vaccine doses per vial if current
10-dose flu vaccine vials are used. Which in large flu vaccine
campaigns suggests an instant increase of thousands to
millions of additional persons who are vaccinated.
2. If 50% of people who inject drugs switch to low dead space
syringes an estimated reduction of 33% of new HIV, and
Hepatitis B and C infections will occur.
3. Reduce incidence of overdose in infants and premature
babies.
Hiealth is committed to providing point-of-care testing (POCT) products in the biomedical in vitro diagnostic (IVD) industry. We have 10 years of experience in medical testing and prevention and control.
In 2020, Hihealth began to focus on the diagnosis and treatment of CO-19. Products and services include rapid detection of colloidal gold, nucleic acid diagnosis, and Chinese medicine prevention and treatment.
Hihealth has passed various professional certifications such as CE/TUV/FDA/EUV. Overseas warehouses in Hong Kong and Europe can guarantee fast delivery.
Hiealth is committed to providing point-of-care testing (POCT) products in the biomedical in vitro diagnostic (IVD) industry. We have 10 years of experience in medical testing and prevention and control.
In 2020, Hihealth began to focus on the diagnosis and treatment of CO-19. Products and services include rapid detection of colloidal gold, nucleic acid diagnosis, and Chinese medicine prevention and treatment.
1.MOQ:
We have the MOQ limit,which is 10000 pieces.
2.Delivery date:
After order confirmed,we will arrange your order immediately,and offer you an
estimated delivery date.
3.Payment Method:
Business to business account.
4.Shipment:
We choose Air cargo or Ocean cargo when the weight is over 300kg,and less
than 300kg,we usually select international EXPRESS(DHL).
5.Visit our factory:
Welcome visit our factory at any time
If you have more questions, please !
